Advertisement
Advertisement

WVE

WVE logo

Wave Life Sciences Ltd. Ordinary Shares

5.95
USD
Sponsored
-0.09
-1.49%
Jun 24, 15:59 UTC -4
Closed
exchange

After-Market

5.97

+0.02
+0.32%

WVE Earnings Reports

Positive Surprise Ratio

WVE beat 10 of 42 last estimates.

24%

Next Report

Date of Next Report
Jul 28, 2026
Estimate for Q2 26 (Revenue/ EPS)
$7.12M
/
-$0.31
Implied change from Q1 26 (Revenue/ EPS)
-81.38%
/
+138.46%
Implied change from Q2 25 (Revenue/ EPS)
-18.15%
/
--

Wave Life Sciences Ltd. Ordinary Shares earnings per share and revenue

On Apr 28, 2026, WVE reported earnings of -0.13 USD per share (EPS) for Q1 26, beating the estimate of -0.33 USD, resulting in a 60.74% surprise. Revenue reached 38.25 million, compared to an expected 9.21 million, with a 315.26% difference. The market reacted with a +8.36% price change (close before vs. close after earnings).
Looking ahead to Q2 26, 12 analysts forecast an EPS of -0.31 USD, with revenue projected to reach 7.12 million USD, implying an increase of 138.46% EPS, and decrease of -81.38% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
enGene Therapeutics Inc. Common Stock
Report Date
Jun 15, 2026 For Q2 26
Estimate
-$0.47
Actual
-$0.43
Surprise
+10.32%
logo
Prenetics Global Limited Class A Ordinary Share
Report Date
Jun 10, 2026 For Q1 26
Estimate
-$1.10
Actual
-$1.61
Surprise
-45.36%
logo
Anixa Biosciences, Inc.
Report Date
Jun 10, 2026 For Q2 26
Estimate
-$0.08
Actual
-$0.07
Surprise
+21.61%
logo
Vistagen Therapeutics, Inc. Common Stock
Report Date
Jun 15, 2026 For Q4 26
Estimate
-$0.34
Actual
-$0.37
Surprise
-7.75%
FAQ
For Q1 2026, Wave Life Sciences Ltd. Ordinary Shares reported EPS of -$0.13, beating estimates by 60.74%, and revenue of $38.25M, 315.26% above expectations.
The stock price moved up 8.36%, changed from $6.94 before the earnings release to $7.52 the day after.
The next earning report is scheduled for Jul 28, 2026.
Based on 12 analysts, Wave Life Sciences Ltd. Ordinary Shares is expected to report EPS of -$0.31 and revenue of $7.12M for Q2 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement